Everolimus Versus Temsirolimus in Metastatic Renal Cell Carcinoma After Progression With Previous Systemic Therapies

Title
Everolimus Versus Temsirolimus in Metastatic Renal Cell Carcinoma After Progression With Previous Systemic Therapies
Authors
Keywords
Genitourinary cancer, Kidney cancer, mTORi, Outcomes, Salvage therapy
Journal
Clinical Genitourinary Cancer
Volume 14, Issue 2, Pages 153-159
Publisher
Elsevier BV
Online
2015-12-18
DOI
10.1016/j.clgc.2015.12.011

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started